Immediate Impact
26 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
Works of Sumeng Li being referenced
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
2021
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sumeng Li | 139 | 35 | 17 | 30 | 17 | 202 | |
| Yi Han | 181 | 94 | 33 | 49 | 9 | 250 | |
| Yuchong Li | 180 | 31 | 28 | 36 | 14 | 287 | |
| Qiran Zhang | 104 | 44 | 36 | 34 | 24 | 213 | |
| Zhou Zhou | 144 | 58 | 58 | 37 | 13 | 299 | |
| Weibiao Zeng | 125 | 80 | 20 | 45 | 19 | 234 | |
| Ottavio Zucchetti | 154 | 74 | 36 | 16 | 10 | 267 | |
| Havva Kocayiğit | 140 | 57 | 38 | 53 | 22 | 208 | |
| Dixuan Jiang | 176 | 59 | 34 | 32 | 11 | 272 | |
| Christophe Langouët-Astrié | 99 | 35 | 38 | 42 | 18 | 285 | |
| Isabel Mur | 139 | 52 | 24 | 18 | 12 | 219 |
All Works
Loading papers...